Phase II study of vinorelbine (NVB) in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck (SCCHN)

被引：0
|
作者：
Degardin, M
Bastit, P
Rolland, F
Armand, JP
Chevallier, B
VanGlabbeke, M
Boudillet, J
Tresca, P
机构：
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：843 / 843
页数：1
相关论文
共 50 条
  • [31] Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck
    Tseng, JE
    Glisson, BS
    Khuri, FR
    Shin, DM
    Myers, JN
    El-Naggar, AK
    Roach, JS
    Ginsberg, LE
    Thall, PF
    Wang, XM
    Teddy, S
    Lawhorn, KN
    Zentgraf, RE
    Steinhaus, GD
    Pluda, JM
    Abbruzzese, JL
    Hong, WK
    Herbst, RS
    CANCER, 2001, 92 (09) : 2364 - 2373
  • [32] Phase II study with docetaxel and cisplatin in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Gedlicka, C
    Formanek, M
    Selzer, E
    Burian, M
    Kornfehl, J
    Fiebiger, W
    Cartellieri, M
    Marks, B
    Kornek, GV
    ONCOLOGY, 2002, 63 (02) : 145 - 150
  • [33] Phase II study of dasatinib in combination with cetuximab in recurrent/metastatic head and neck squamous cell carcinoma
    Stabile, Laura P.
    Egloff, Ann Marie
    Zhou, Pei
    Gooding, William E.
    Grandis, Jennifer R.
    Bauman, Julie E.
    CANCER RESEARCH, 2016, 76
  • [34] Phase II study of cetuximab and lenalidomide in recurrent/metastatic squamous cell carcinoma of the head and neck.
    Taylor, Rodney J.
    Saloura, Vassiliki
    Wong, Richard
    Goloubeva, Olga
    Silpino, Lorna
    de Souza, Jonas
    Seiwert, Tanguy
    Vokes, Everett
    Cohen, Ezra
    Villaflor, Victoria
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [35] Paclitaxel and carboplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck. A phase II study.
    Hiller, S
    Mergenthaler, HG
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 507S - 507S
  • [36] Phase II Clinical and Exploratory Biomarker Study of Dacomitinib in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck
    Kim, Han Sang
    Kwon, Hyeong Ju
    Jung, Inkyung
    Yun, Mi Ran
    Ahn, Myung-Ju
    Kang, Byung Woog
    Sun, Jong-Mu
    Kim, Sung Bae
    Yoon, Dok-Hyun
    Park, Keon Uk
    Lee, Se-Hoon
    Koh, Yoon Woo
    Kim, Se Hun
    Choi, Eun Chang
    Koo, Dong Hoe
    Sohn, Jin Hee
    Kim, Bomi
    Kwon, Nak-Jung
    Yun, Hwan Jung
    Lee, Min Goo
    Lee, Ji Hyun
    Kim, Tae-Min
    Kim, Hye Ryun
    Kim, Joo Hang
    Paik, Soonmyung
    Cho, Byoung Chul
    CLINICAL CANCER RESEARCH, 2015, 21 (03) : 544 - 552
  • [37] Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma
    Nutting, C. M.
    van Herpen, C. M. L.
    Miah, A. B.
    Bhide, S. A.
    Machiels, J. -P.
    Buter, J.
    Kelly, C.
    de Raucourt, D.
    Harrington, K. J.
    ANNALS OF ONCOLOGY, 2009, 20 (07) : 1275 - 1279
  • [38] A phase II study of combination chemotherapy with capecitabine and cisplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck
    Won, Y. -W.
    Park, Y. H.
    Ahn, M. J.
    Do, I. -G.
    Ko, Y. H.
    Park, K.
    ANNALS OF ONCOLOGY, 2011, 22 (02) : 417 - 423
  • [39] Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study
    Cohen, Ezra E. W.
    Davis, Darren W.
    Karrison, Theodore G.
    Seiwert, Tanguy Y.
    Wong, Stuart J.
    Nattam, Sreenivasa
    Kozloff, Mark F.
    Clark, Joseph I.
    Yan, Duen-Hwa
    Liu, Wen
    Pierce, Carolyn
    Dancey, Janet E.
    Stenson, Kerstin
    Blair, Elizabeth
    Dekker, Allison
    Vokes, Everett E.
    LANCET ONCOLOGY, 2009, 10 (03): : 247 - 257
  • [40] Cetuximab monotherapy is active in patients (pts) with platinum-refractory recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN): Results of a phase II study.
    Trigo, J
    Hitt, R
    Koralewski, P
    Diaz-Rubio, E
    Rolland, F
    Knecht, R
    Amellal, N
    Bessa, EH
    Baselga, J
    Vermorken, JB
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 488S - 488S
12345